clinicaltrialsarena1d
MSD and AstraZeneca report positive topline data from Koselugo trial for NF1
Credit: TimeImage Production/Shutterstock. Merck & Co (MSD), Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET trial, assessing the efficacy and ...
Drug Store News1d
FDA gives Lupin tentative nod for generic Isentress
Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...
FDA wants to pull decongestant found in many cold, allergy medicines
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...
Commercial Observer6d
Pet Store, Wellness Company Ink Deals at MAG Partners’ Chelsea Development
Pet store Pet Evolution and wellness company Saint have signed 10-year leases for a total of 3,100 square feet at MAG ...
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
I'm not saying the stocks on this list can generate those kinds of returns. But they are trading at discounted valuations, and investing $5,000 into them can be a good move. Prudent investors will ...